SciClone Pharmaceuticals, Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for SciClone Pharmaceuticals, In are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 21, 2019 and ending today September 19, 2019. Click here to learn more.
SciClone Pharmaceuticals, In cannot be verified against its exchange. Apparently, SciClone Pharmaceuticals, is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

SciClone Pharmaceuticals, Key Fundamentals

SciClone Pharmaceuticals, Against Markets

SciClone Pharmaceuticals, In cannot be verified against its exchange. Apparently, SciClone Pharmaceuticals, is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, offer therapies for oncology, infectious diseases, and cardiovascular disorders in the Peoples Republic of China, the United States, and Hong Kong.. The public information regarding SciClone Pharmaceuticals, In's current market price is not available at this time.
NameSciClone Pharmaceuticals, In
CEO of China OperationsHong ZhaoView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address950 Tower Lane, Suite 900, Foster City, CA 94404, United States
ExchangeNASDAQ
CIK Number0000880771
ISINUS80862K1043
BenchmarkDOW
Websitewww.sciclone.com
Phone650 358 3456

SciClone Pharmaceuticals, Corporate Directors

Richard Hawkins Independent Director
Gregg Lapointe Independent Director
Nancy Chang Director
See also World Market Map. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com